Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT04315740 Completed - Asthma Clinical Trials

Acute Health Effects Due to Ultrafine Particles From Candles and Cooking

Ultrafine
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

People spend up to 90% of their life indoor, and the way we live and behave in our homes has substantial effects on our health and well-being. Particle contamination is suggested to have substantial negative effects on health, with candles and cooking emitting the largest amount of particles, thus being the largest contributors to indoor air pollution. The overall aim of the present project is to contribute to increased understanding of the association between indoor particulate air pollution and health and well-being.

NCT ID: NCT04310696 Completed - Asthma Clinical Trials

Comparison of Buteyko Technique and Pursed Lip Breathing in Asthma

Start date: August 30, 2018
Phase: N/A
Study type: Interventional

The objective of the study was to compare the effects of Buteyko breathing technique and pursed lip breathing technique in the management of asthma. A randomized controlled trial was conducted on 60 asthmatic patients randomly allocated to Buteyko technique group and pursed lip breathing group. Both the groups received 4 weeks of treatment, 3 times per week. Data was collected at base line, 2nd week and 4th week. Outcome measurements included FVC, FEV, PEFR and Asthma Control Test Questionnaire scores. Data analysis was carried out on Statistical Package for the Social Sciences (SPSS) v.21.0. Confidence interval was kept at 95% and a p-value of less than 0.05 was considered significant.

NCT ID: NCT04305405 Completed - Clinical trials for Severe Uncontrolled Asthma

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

TATE
Start date: November 21, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the PK, PD and long-term safety of Benralizumab administered subcutaneously in 30 children aged 6 to 11 years with severe eosinophilic asthma. Up to an additional 3 Japanese patients aged 12 to 14 years will be enrolled to meet local regulatory requirements.

NCT ID: NCT04302610 Completed - Asthma Clinical Trials

Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in Asthma

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

The overall aim of this study is to determine if face masks that can warm and humidify air can improve overall asthma control and markers of airway health during exercise in cold dry environments. We will investigate the potential protective benefits of the face masks against exercise induced asthma during 1) a "one-off" bout of exercise in a cold dry environment and 2) over the course of a four week period, exercising three times per week in a cold dry environment.

NCT ID: NCT04289714 Completed - Asthma in Children Clinical Trials

Novel Electronic Monitoring Devices (NEMD) to Monitor Adherence in Children With Asthma

NEMD
Start date: October 12, 2018
Phase: N/A
Study type: Interventional

This is a feasibility study to assess novel electronic monitoring devices for monitoring adherence in children with asthma who are on inhaled corticosteroids (ICS) It is a mixed method (quantitative and qualitative) open label, pragmatic randomised feasibility study with two main aims: 1. To assess the feasibility of 4 novel electronic monitoring devices in children aged 6-16 years with asthma, in terms of usability and acceptability by patients/ guardians and healthcare professionals (qualitative study) 2. To evaluate the accuracy of these devices and assess whether they impact on asthma control (quantitative study). The duration of study is 16 weeks.

NCT ID: NCT04289441 Completed - Asthma in Children Clinical Trials

Probiotics in Paediatric Asthma Management

ProPAM
Start date: April 21, 2017
Phase: N/A
Study type: Interventional

Randomized controlled double-blind trial in a child population with allergic asthma and recurring wheezing, undergoing probiotic treatment with Bifiasthm with the aim of assessing the reduction in asthma attacks.

NCT ID: NCT04277078 Completed - Asthma Clinical Trials

Predicting Intubation of Patients Hospitalised for Acutely Attacked Asthma

Start date: February 1, 2020
Phase:
Study type: Observational

Although the asthmatic treatments currently be effective in term of efficacy of inhaled medications and good clinical outcome including symptom controlled and asthma exacerbation number, the large number of worse event still have been reported. Few cases eventually have been intubated and died even though using optimal medication. In this study, we will search to identify factors that may influence intubation in hospitalised patient with asthmatic attack.

NCT ID: NCT04272463 Completed - Severe Asthma Clinical Trials

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

ANANKE
Start date: March 13, 2020
Phase:
Study type: Observational

This is an observational, Italian multi-center, retrospective cohort study with enrollment visit on patients suffering from severe eosinophilic asthma who started benralizumab in the Sampling Program or as per normal clinical practice in Italy.

NCT ID: NCT04267666 Completed - Clinical trials for Postmenopausal Symptoms

Inspiratory Muscle Strength Training and Incentive Spirometer on Postmenopausal Asthmatic Women

training
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Objective: To compare the effectiveness of inspiratory muscle training (IMT) and incentive spirometer on ventilatory functions in post-menopausal asthmatic women. Participants and methods: A total of forty postmenopausal women suffering from asthma, their ages ranged from 50 to 60 years old, and their body mass index of the patient don't exceed 30kg/m2. They were recruited from patient chest clinic in Kasr -El- Ainy Teaching Hospital, Cairo University, Egypt.

NCT ID: NCT04265105 Completed - Asthma Clinical Trials

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

Start date: December 22, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Investigators will test the superiority of Superiority Trial of Fluticasone-Vilanterol as needed in mild asthma compared to standard of care